Chem Shift validation: AVS_full
BMRB Entry DOI: doi:10.13018/BMR53026
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
All files associated with the entry
Citation: Petrovic, Ivana; Tatli, Meltem; Desai, Samit; Grahl, Anne; Ni, Dongchun; Stahlberg, Henning; Spang, Anne; Grzesiek, Stephan; Abiko, Layara. "Arrestin recognizes GPCRs independently of the receptor state" Proc. Natl. Acad. Sci. U.S.A. 122, e2501487122-e2501487122 (2025).
PubMed: 40372433
Assembly members:
entity_1, polymer, 315 residues, Formula weight is not available
entity_CVD, non-polymer, 406.474 Da.
Natural source: Common Name: turkey Taxonomy ID: 9103 Superkingdom: Eukaryota Kingdom: Metazoa Genus/species: Meleagris gallopavo
Experimental source: Production method: recombinant technology Host organism: Spodoptera frugiperda Vector: pFastBac1
| Data type | Count |
| 15N chemical shifts | 71 |
| 1H chemical shifts | 71 |
| Entity Assembly ID | Entity Name | Entity ID |
|---|---|---|
| 1 | YY-b1-adrenergic receptor in complex with isoprenaline, conformer 1 | 1 |
| 2 | Carvedilol | 2 |
Entity 1, YY-b1-adrenergic receptor in complex with isoprenaline, conformer 1 315 residues - Formula weight is not available
YY refers to the native residues Y227 (5x58) and Y343 (7x53), which were reintroduced from the fully thermostabilized Turkey_TS-B1AR construct.
| 1 | MET | GLY | ALA | GLU | LEU | LEU | SER | GLN | GLN | TRP | ||||
| 2 | GLU | ALA | GLY | MET | SER | LEU | LEU | MET | ALA | LEU | ||||
| 3 | VAL | VAL | LEU | LEU | ILE | VAL | ALA | GLY | ASN | VAL | ||||
| 4 | LEU | VAL | ILE | ALA | ALA | ILE | GLY | SER | THR | GLN | ||||
| 5 | ARG | LEU | GLN | THR | LEU | THR | ASN | LEU | PHE | ILE | ||||
| 6 | THR | SER | LEU | ALA | CYS | ALA | ASP | LEU | VAL | VAL | ||||
| 7 | GLY | LEU | LEU | VAL | VAL | PRO | PHE | GLY | ALA | THR | ||||
| 8 | LEU | VAL | VAL | ARG | GLY | THR | TRP | LEU | TRP | GLY | ||||
| 9 | SER | PHE | LEU | CYS | GLU | LEU | TRP | THR | SER | LEU | ||||
| 10 | ASP | VAL | LEU | CYS | VAL | THR | ALA | SER | VAL | GLU | ||||
| 11 | THR | LEU | CYS | VAL | ILE | ALA | ILE | ASP | ARG | TYR | ||||
| 12 | LEU | ALA | ILE | THR | SER | PRO | PHE | ARG | TYR | GLN | ||||
| 13 | SER | LEU | MET | THR | ARG | ALA | ARG | ALA | LYS | VAL | ||||
| 14 | ILE | ILE | CYS | THR | VAL | TRP | ALA | ILE | SER | ALA | ||||
| 15 | LEU | VAL | SER | PHE | LEU | PRO | ILE | MET | MET | HIS | ||||
| 16 | TRP | TRP | ARG | ASP | GLU | ASP | PRO | GLN | ALA | LEU | ||||
| 17 | LYS | CYS | TYR | GLN | ASP | PRO | GLY | CYS | CYS | GLU | ||||
| 18 | PHE | VAL | THR | ASN | ARG | ALA | TYR | ALA | ILE | ALA | ||||
| 19 | SER | SER | ILE | ILE | SER | PHE | TYR | ILE | PRO | LEU | ||||
| 20 | LEU | ILE | MET | ILE | PHE | VAL | TYR | LEU | ARG | VAL | ||||
| 21 | TYR | ARG | GLU | ALA | LYS | GLU | GLN | ILE | ARG | LYS | ||||
| 22 | ILE | ASP | ARG | ALA | SER | LYS | ARG | LYS | THR | SER | ||||
| 23 | ARG | VAL | MET | LEU | MET | ARG | GLU | HIS | LYS | ALA | ||||
| 24 | LEU | LYS | THR | LEU | GLY | ILE | ILE | MET | GLY | VAL | ||||
| 25 | PHE | THR | LEU | CYS | TRP | LEU | PRO | PHE | PHE | LEU | ||||
| 26 | VAL | ASN | ILE | VAL | ASN | VAL | PHE | ASN | ARG | ASP | ||||
| 27 | LEU | VAL | PRO | LYS | TRP | LEU | PHE | VAL | ALA | PHE | ||||
| 28 | ASN | TRP | LEU | GLY | TYR | ALA | ASN | SER | ALA | MET | ||||
| 29 | ASN | PRO | ILE | ILE | TYR | CYS | ARG | SER | PRO | ASP | ||||
| 30 | PHE | ARG | LYS | ALA | PHE | LYS | ARG | LEU | LEU | ALA | ||||
| 31 | PHE | PRO | ARG | LYS | ALA | ASP | ARG | ARG | LEU | HIS | ||||
| 32 | HIS | HIS | HIS | HIS | HIS |
Entity 2, Carvedilol - C24 H26 N2 O4 - 406.474 Da.
| 1 | CVD |
sample_1: Turkey B1AR, [U-15N]-Tyr, 150 uM; Carvedilol 2 mM; TRIS 20 mM; sodium chloride 100 mM; n-Decyl-b-D-maltoside 65 mM; ascorbate 20 mM; sodium azide 0.02%; D2O 5%
sample_2: Turkey B1AR, [U-15N]-Tyr, 100 uM; Carvedilol 1 mM; TRIS 20 mM; sodium chloride 100 mM; n-Decyl-b-D-maltoside 65 mM; ascorbate 20 mM; sodium azide 0.02%; D2O 5%
sample_3: Turkey B1AR, [U-15N]-Val, 95 uM; Carvedilol 1 mM; TRIS 20 mM; sodium chloride 100 mM; n-Decyl-b-D-maltoside 65 mM; ascorbate 20 mM; sodium azide 0.02%; D2O 5%
sample_4: Turkey B1AR, [U-15N]-Val, 95 uM; Carvedilol 1 mM; TRIS 20 mM; sodium chloride 100 mM; n-Decyl-b-D-maltoside 65 mM; ascorbate 20 mM; sodium azide 0.02%; D2O 5%
sample_conditions_1: pH: 7.5; pressure: 1 atm; temperature: 304 K
| Name | Sample | Sample state | Sample conditions |
|---|---|---|---|
| 2D 1H-15N TROSY | sample_1 | isotropic | sample_conditions_1 |
| 2D 1H-15N TROSY | sample_2 | isotropic | sample_conditions_1 |
| 2D 1H-15N TROSY | sample_3 | isotropic | sample_conditions_1 |
| 2D 1H-15N TROSY | sample_4 | isotropic | sample_conditions_1 |
NMRDraw v11.4 - chemical shift assignment, peak picking
CcpNMR v2.4.2 - data analysis
Download HSQC peak lists in one of the following formats:
CSV: Backbone
or all simulated peaks
SPARKY: Backbone
or all simulated peaks